"Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux
- PMID: 30248432
- DOI: 10.1016/j.neuint.2018.09.008
"Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux
Abstract
Synthetic cathinone derivatives are a new class of psychoactive substances (NPS), also known as "bath salts", designed to exert psychostimulant effects resembling those of well-known psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). As major constituents of bath salts, the cathinone derivatives 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone), have received considerable media attention. MDPV and mephedrone interfere with the function of the high affinity transporters for dopamine (DAT), norepinephrine (NET) and serotonin (SERT), resulting in increased extracellular levels of these monoamines, though their mechanism of action differs. MDPV acts as a non-transported inhibitor of DAT, NET and SERT, whereas mephedrone promotes transporter-mediated release in an amphetamine-like fashion. MDPV and mephedrone are often taken together, creating a conundrum in as much as non-transported inhibitors, like MDPV, prevent mephedrone-induced reverse transport via DAT, NET and SERT. Here we provide evidence supporting a role for organic cation transporter 3 (OCT3) in the actions of mephedrone, which may account for its ability to enhance effects of MDPV. We show that mephedrone can induce substrate efflux via OCT3 in the presence of MDPV. Real-time recordings of the fluorescent OCT3 substrate (4-(4-dimethylamino)styryl)-N-methylpyridinium (ASP+) and radiotracer-flux studies using [3H]1-methyl-4-phenyl-pyridinium (MPP+), demonstrated that OCT3 is MDPV-insensitive when expressed in human embryonic kidney (HEK293) cells. Ex vivo experiments performed in cultured superior cervical ganglia (SCG) cells, rich in NET and OCT3, revealed that mephedrone induces [3H]MPP+ release in an OCT3-dependent manner when NET is fully occupied with MDPV. These results extend our recent findings that OCT3 is key in the mechanism of action of amphetamine-induced substrate release. OCT3 likewise appears to be a mechanism through which mephedrone can induce release of monoamines, thereby accounting for the paradoxically more potent psychostimulant effects of MDPV taken together with mephedrone, and greater risk for deleterious side effects.
Keywords: Cathinones; Dopamine transporter; Monoamines; Organic cation transporter 3; Psychostimulant.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.J Neurochem. 2015 Apr;133(2):211-22. doi: 10.1111/jnc.13048. Epub 2015 Mar 2. J Neurochem. 2015. PMID: 25626880 Free PMC article.
-
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.Br J Pharmacol. 2013 Apr;168(7):1750-7. doi: 10.1111/bph.12061. Br J Pharmacol. 2013. PMID: 23170765 Free PMC article.
-
Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.Psychopharmacology (Berl). 2013 Jun;227(3):493-9. doi: 10.1007/s00213-013-2967-2. Epub 2013 Jan 31. Psychopharmacology (Berl). 2013. PMID: 23371489 Free PMC article.
-
Psychoactive "bath salts": not so soothing.Eur J Pharmacol. 2013 Jan 5;698(1-3):1-5. doi: 10.1016/j.ejphar.2012.11.020. Epub 2012 Nov 23. Eur J Pharmacol. 2013. PMID: 23178799 Free PMC article. Review.
-
Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.Adv Pharmacol. 2014;69:581-620. doi: 10.1016/B978-0-12-420118-7.00015-9. Adv Pharmacol. 2014. PMID: 24484988 Free PMC article. Review.
Cited by
-
Organic cation transporters in psychiatric and substance use disorders.Pharmacol Ther. 2024 Jan;253:108574. doi: 10.1016/j.pharmthera.2023.108574. Epub 2023 Dec 9. Pharmacol Ther. 2024. PMID: 38072333 Free PMC article. Review.
-
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse.Mol Psychiatry. 2023 Jul;28(7):2934-2945. doi: 10.1038/s41380-023-02064-5. Epub 2023 Jun 13. Mol Psychiatry. 2023. PMID: 37308680 Free PMC article.
-
The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.Handb Exp Pharmacol. 2021;266:199-214. doi: 10.1007/164_2021_469. Handb Exp Pharmacol. 2021. PMID: 33993413 Review.
-
Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?Front Pharmacol. 2021 Jan 20;11:609811. doi: 10.3389/fphar.2020.609811. eCollection 2020. Front Pharmacol. 2021. PMID: 33551812 Free PMC article.
-
From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC.Arch Toxicol. 2021 Apr;95(4):1443-1462. doi: 10.1007/s00204-021-02990-9. Epub 2021 Feb 7. Arch Toxicol. 2021. PMID: 33550444
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials